Clinical Trials Browser

Phase 3 × Unknown × Tamoxifen × Clear all

NCT01579734 2023-06-28

HOT

Phase 3 Unknown

Breast Neoplasms

NCT00412022 2023-03-24

HOBOE

Phase 3 Unknown

Breast Neoplasms

NCT02914158 2023-01-17

ASPAIT

Phase 3 Unknown

Breast Neoplasms

NCT05016349 2021-08-23

Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.

Phase 3 Unknown

Breast Cancer Female

NCT01758146 2020-03-04

Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors

Phase 3 Unknown

Breast Neoplasms, Obesity

NCT00541086 2020-02-07

Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery

Phase 3 Unknown

Breast Neoplasms

NCT04046159 2019-08-06

Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ

Phase 3 Unknown

Carcinoma, Intraductal, Noninfiltrating

NCT03137368 2018-10-31

STEP

Phase 3 Unknown

Breast Neoplasms

NCT03351062 2017-11-22

Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer

Phase 3 Unknown

Breast Neoplasms

NCT02097459 2016-05-25

Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer

Phase 3 Unknown

Breast Neoplasms

NCT00003418 2013-12-19

Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer

Phase 3 Unknown

Breast Neoplasms

NCT00003678 2013-12-19

Tamoxifen in Treating Women With Breast Cancer

Phase 3 Unknown

20,000 enrolled

Breast Neoplasms

NCT00010140 2013-12-18

Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer

Phase 3 Unknown

Breast Neoplasms

NCT00003679 2013-11-06

Combination Chemotherapy in Treating Women With Breast Cancer

Phase 3 Unknown

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00003680 2013-11-06

Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer

Phase 3 Unknown

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT01622361 2013-09-30

NEST

Phase 3 Unknown

Breast Neoplasms

NCT00002460 2013-08-07

Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer

Phase 3 Unknown

Breast Neoplasms

NCT00006030 2013-08-07

Comparison of Four Different Treatment Regimens in Treating Women With Stage I Breast Cancer

Phase 3 Unknown

Breast Neoplasms

NCT00629278 2013-08-07

Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer

Phase 3 Unknown

Breast Neoplasms

NCT00896155 2011-08-30

CONSET

Phase 3 Unknown

Breast Neoplasms, Pulmonary Fibrosis

NCT00912548 2009-06-16

ASTRRA

Phase 3 Unknown

Breast Neoplasms